New Paradigms for Clinical Drug Development in the Genomic Era Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute .
FDA-Industry-Biomarkers.ppt
Pearls and myths in sle
Transforming Correlative Science to Predictive Personalized Medicine Richard Simon, D.Sc. National Cancer Institute .
Use of Archived Tissue in Evaluating the Medical Utility of Prognostic & Predictive Biomarkers Richard Simon, D.Sc. Chief, Biometric Research Branch National.
Issues to Consider in HIV Resistance Testing Jason Tokumoto, MD National HIV/AIDS Clinicians’ Consultation Center.
Statistical Challenges for Predictive Onclogy Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute .
Validation of Predictive Classifiers Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute .
Development and Use of Predictive Biomarkers Dr. Richard Simon.
Use of Prognostic & Predictive Genomic Biomarkers in Clinical Trial Design Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute.
Validation of Predictive Classifiers
New Approaches to Clinical Trial Design Development of New Drugs & Predictive Biomarkers Richard Simon, D.Sc. Chief, Biometric Research Branch National.
